RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 290-296

  Martinand, Camille ^a   Montavon, Céline ^a,b   Salehzada, Tamim ^a   Silhol, Michelle ^a   Lebleu, Bernard ^a   Bisbal, Catherine ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; RIBONUCLEASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; VIRUS REPLICATION;

EID: 0032889556     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.290-296.1999     Document Type: Article

References (14)

1. Baron, S., D. Coppenhaver, F. Dianzani, W. Fleischmann, T. Hughes, G. Kumpel, D. Niesel, G. Stanton, and S. Tyring. 1992. Cell effects of IFNs and animal studies, p. 271-287. In S. Baron (ed.), Interferon: principles and medical applications. The University of Texas, Galveston, Tex.
2. Bayard, B., C. Bisbal, and B. Lebleu. 1986. Activation of ribonuclease L by (2′-5′)(A)4-poly(L-Iysine) conjugates in intact cells. Biochemistry 25:3730-3736.
3. Bisbal, C., C. Martinand, M. Silhol, B. Lebleu, and T. Salehzada. 1995. Cloning and characterization of a RNase L inhibitor. A new component of the interferon-regulated 2-5A pathway. J. Biol. Chem. 270:13308-13317.
4. Bisbal, C., T. Salehzada, B. Lebleu, and B. Bayard. 1989. Characterization of two murine (2′-5′)(A)n-dependent endonucleases of different molecular mass. Eur. J. Biochem. 179:595-602.
5. Carter, W. A., D. R. Strayer, I. Brodsky, M. Lewin, M. G. Pellegrino, L. Einck, H. F. Henriques, G. L. Simon, D. M. Parenti, R. G. Scheib, et al. 1987. Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex. Lancet 1:1286-1292.
6. Cathala, G., J. F. Savouret, B. Mendez, B. L. West, M. Karin, J. A. Martial, and J. D. Baxter. 1983. A method for isolation of intact, translationally active ribonucleic acid. DNA 2:329-335.
7. Cayley, P. J., J. A. Davies, K. G. McCullagh, and I. M. Kerr. 1984. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur. J. Biochem. 143:165-174.
8. Chebath, J., P. Benech, M. Revel, and M. Vigneron. 1987. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330:587-588.
9. Coccia, E. M., G. Romeo, A. Nissim, G. Marziali, R. Albertini, E. Affabris, A. Battistini, G. Fiorucci, R. Orsatti, and G. B. Rossi. 1990. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179:228-233.
10. Dong, B., and R. H. Silverman. 1995. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270:4133-4137.
11. Floyd-Smith, G., E. Slattery, and P. Lengyel. 1981. Interferon action: RNA cleavage pattern of a (2′-5′)oligoadenylate-dependent endonuclease. Science 212:1030-1032.
12. Hassel, B. A., A. Zhou, C. Sotomayor, A. Maran, and R. H. Silverman. 1993. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12:3297-3304.
13. Kerr, I. M., and R. E. Brown. 1978. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75:256-260.
14. Knight, M., P. J. Cayley, R. H. Silverman, D. H. Wreschner, C. S. Gilbert, R. E. Brown, and I. M. Kerr. 1980. Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature 288:189-192.